An ongoing dialogue on HIV/AIDS, infectious diseases,
September 12th, 2009
49th ICAAC Starts Today
Browsing through the program book, I see these topics extensively covered:
- H1N1 and seasonal flu, in all their glory — transmission, pathogenesis, treatment, predictions
- Highly resistant GNR — acinetobacter, carbapenemases, ESBL, etc.
- MRSA — my personal favorite
- C diff — though perhaps a little less this year?
While no one expects ICAAC to be an HIV-focused meeting, usually there are a few important papers presented — last year, for example, NA-ACCORD and raltegravir in treatment-naives debuted at ICAAC.
But unless I’m missing something, I don’t see anything this year on the HIV front of comparable importance. One year blip or a sign of the times?
(FYI, the CDA — that’s the California Dental Association — is also having a meeting here. Their meeting-goers have much better teeth than ID doctors/microbiologists.)
Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
NEJM Journal Watch — Recent Infectious Disease Articles- Sulopenem Etzadroxil plus Probenecid (Orlynvah) for Uncomplicated Urinary Tract Infections
- Radiolabeled p-Aminobenzoic Acid as a Marker to Detect Bacterial Endocarditis
- Clostridioides difficile Vaccines: Promising Contenders
- Observations from ID and Beyond: Marking a Social Media Mass Migration — Until the Next One
- Incidence of Autoimmune Diseases Involving the Skin, After Acute COVID-19